Introduction Major depressive disorder (MDD) is a major global healthcare challenge. This is, in part, due to the lack of treatment response and chronic course of MDD. Such a course of illness is ...

Earlier identification is also of interest due to the possibility that earlier intervention may be more effective with more ...

Summer depression is real and affects millions. Learn the surprising symptoms of summer SAD and discover expert strategies to ...

The growing global burden of neuropsychiatric disorders is a critical driver for the treatment market. With over 9.1 million annual deaths attributed to neurological diseases and an additional 8 ...

A new study led by Cedars-Sinai found a pattern of racial bias in treatment recommendations generated by leading artificial ...

Struggling with chronic pain and stress? Discover how combining chiropractic care with psychotherapy can create a healing ...

Depression affects 1%-2% of children younger than 13 in the U.S. and can arise as early as age 3, but a specialized ...

Depression affects 1–2% of children younger than 13 in the U.S. and can arise as early as age 3, but a specialized ...

Difficult-to-treat psychiatric disorders, such as complex PTSD, chronic or treatment-resistant depression, and treatment-resistant anxiety disorders, often ...

Cite this: Brief Treatment Strategies for Major Depressive Disorder: Advice for the Primary Care Clinician - Medscape - Feb 03, 2004.

Abstract The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression Background Ketamine exerts potent but ...

New Zealand on Wednesday approved the medicinal use of psilocybin, a hallucinogenic compound notably found in “magic mushrooms”. Deputy Prime Minister David Seymour said rules had been relaxed ...